Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-01-11
2011-01-11
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S122000, C546S083000, C544S279000, C544S117000, C514S264100, C514S264110, C514S234200, C514S293000
Reexamination Certificate
active
07868018
ABSTRACT:
The invention provides compounds of Formula I:wherein R1-R6are described in the Summary of the Invention; the pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of the Abl, Bcr-Abl, BMX, BTK, CHK2, b-RAF, c-RAF, CSK, c-SRC, Fes, FGFR3, Flt3, IKKα, IKKβ, JNK2α2, Lck, Met, MKK4, MKK6, MST2, NEK2, p70S6K, PDGFRβ, PKA, PKBα, PKD2, Rsk1, SAPK2α, SAPK2β, SAPK3, SGK, Tie2 and TrkB kinases.
REFERENCES:
patent: 4055566 (1977-10-01), Hardtmann et al.
patent: 2003/0171584 (2003-09-01), Chen et al.
patent: 2009/0118311 (2009-05-01), Davidson
patent: 2009/0171089 (2009-07-01), Cywin et al.
patent: WO9615128 (1996-05-01), None
patent: WO0155147 (2001-08-01), None
patent: WO2005011597 (2005-02-01), None
patent: WO2005034869 (2005-04-01), None
patent: WO2006039718 (2006-04-01), None
patent: WO2006135824 (2006-12-01), None
Wikipedia, Kinase, http://en.wikipedia.org/wiki/Kinase, May 5, 2010.
Connolly, CJC et al., “Discovery and structure-activity studies of a novel series of pyrido[2,3-d]pyrimidine tyrosine kinase inhibitors”, Bioorganic and Medicinal Chemistry Letters, Sep. 23, 1997, pp. 2415-2420, vol. 7, No. 18.
Hamby, JM et al., “Structure-activity relationships for a novel series of pyrido[2,3-d]pyrimidine tyrosine kinase inhibitors”, Journal of Medicinal Chemistry, 1997, pp. 2296-2303, vol. 40, No. 15.
Gray Nathanael S.
Liu Yi
Wang Xing
Xie Yongping
Zhang Guobao
Genomics Institute of the Novartis Research Foundation
IRM LLC
Jaisle Cecilia M
Reid Scott W.
Wilson James O
LandOfFree
Compounds and compositions as protein kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds and compositions as protein kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds and compositions as protein kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2667191